Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Randomised clinical trial: otilonium bromide improves frequency of abdominal pain
Formula: C19H21NO2
Rebalka IA
110(6):2140-7
Poziotinib l (chloride) Randomised clinical trial: otilonium bromidePoziotinib , also known as HM781 36B and NOV120101, is an orally bioavailable, quinazoline based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity. HM781 36B irreversibly inhibits EGFR (HER1 or ErbB1), including EGFR mutants, HER2, and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. EGFRs, cell surface receptor tyrosine kinases, are often upregulated in a
US$ 11.50
US$ 59.95
US$ 13.99
US$ 34.99
US$ 34.99
US$ 20.99
US$ 32.95
US$ 10.90